Pfizer cuts 2022 earnings outlook despite strong first-quarter Covid vaccine and antiviral sales

Pfizer said it sold $13.2 billion of its Covid vaccine and $1.5 billion of its antiviral treatment Paxlovid.

Previous post Uber reports first-quarter earnings on Wednesday: Here’s what Wall Street’s watching
Next post Natural gas surges 9% to highest level since 2008 as Russia’s war roils energy markets